2Elliott HL,Meredith PA.Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade:further analysis of the‘ACTION'database in patients with angina[J].J Hum Hypertens,2011,25(1):63-70.
3Briguori C,Airoldi F,Morici N,et al.New pharmacological protocols to prevent or reduce contrast media nephropathy[J].Minerva Cardioangiol,2005,53(1):49-58.
7Rihal CS,Textor SC,Grill DE,et al.Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention[J].Circulation,2002,105(19):2259-2264.
8Nikolsky E,Aymong ED,Dangas G,et al.Radiocontrast nephropathy:identifying the high-risk patient and the implications exacerbating renal function[J].Rev Cardiovasc Med,2003,4(Suppl 1):S7-S14.
9Umruddin Z,Moe K,Superdock K.ACE inhibitor or angiotensinⅡreceptor blocker use is a risk factor for contrast-induced nephropathy[J].J Nephrol,2012,25(5):776-781.
10Ad-hoc working group of ERBP,Fliser D,Laville M,et al.A European Renal Best Practice(ERBP)position statement on the Kidney Disease Improving Global Outcomes(KDIGO)clinical practice guidelines on acute kidney injury:part 1:definitions,conservative management and contrast-induced nephropathy[J].Nephrol Dial Transplant,2012,27(12):4263-4272.
